US stock · US markets · public data

JNJ

Johnson & Johnson · Healthcare

Reference price$252.10Updated according to the public source
P/E29.21
P/B7.14
ROE25.74%
DY 12M2.08%
Net margin—
Net debt/equity—
Market capUS$ 607.5 B
Volume (shares)4,030,170
SectorHealthcare
Overview

About JNJ

Demonstrações públicas consolidadas + SEC Company Facts

Johnson & Johnson (JNJ) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
10/22
04/23
07/23
10/23
03/24
06/24
09/24
03/25
06/25
09/25
03/26
06/26
Income in shown records$14.79
DY 12M2.08%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-28Dividendo pago$1.34
Period ending 2026-03-29Dividendo pago$1.30
Period ending 2025-09-28Dividendo pago$1.30
Period ending 2025-06-29Dividendo pago$1.30
Period ending 2025-03-30Dividendo pago$1.24
Period ending 2024-09-29Dividendo pago$1.24

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$85,159,000,000.00$88,821,000,000.00$94,193,000,000.00—
Gross Profit$58,606,000,000.00$61,350,000,000.00$63,937,000,000.00—
Operating Income————
Net Income$35,153,000,000.00$14,066,000,000.00$26,804,000,000.00—
EPS Diluted$13.72 / share$5.79 / share$11.03 / share—

Balance sheet

Account2023202420252026
Total Assets$167,558,000,000.00$180,104,000,000.00$199,210,000,000.00—
Total Liabilities$98,784,000,000.00$108,614,000,000.00$117,666,000,000.00—
Total Equity$68,774,000,000.00$71,490,000,000.00$81,544,000,000.00—
Long-term Debt$25,881,000,000.00$30,651,000,000.00$39,438,000,000.00—
Current Debt$3,451,000,000.00$5,983,000,000.00$8,495,000,000.00—
Shares Outstanding2,604,286,303 shares2,408,767,228 shares2,407,616,693 shares2,409,898,936 shares
Cash & Investments$22,927,000,000.00$24,522,000,000.00$20,102,000,000.00—
Dívida Líquida$6,405,000,000.00$12,112,000,000.00$27,831,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$22,791,000,000.00$24,266,000,000.00$24,530,000,000.00—
Capital Expenditures$4,543,000,000.00$4,424,000,000.00$4,832,000,000.00—
Free Cash Flow$18,248,000,000.00$19,842,000,000.00$19,698,000,000.00—
FAQ

Frequently asked questions

What is the price of JNJ?

The reference price available for JNJ is $252.10.

What is the P/E of JNJ?

The P/E ratio of JNJ is 29.21. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of JNJ?

The P/B of JNJ is 7.14. This compares price with reported book value per share.

What is the ROE of JNJ?

The ROE (Return on Equity) of JNJ is 25.74%. This relates the reported net result to shareholders' equity.

What is the dividend yield of JNJ?

The dividend yield of JNJ is 2.08%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of JNJ?

The market capitalization of JNJ is US$ 607.5 B.

What sector is JNJ in?

JNJ operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.